Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
68
Top-10 weight
39.60%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
34
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
606.5
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | Fidelity Securities Lending Cash Central Fund | — | 7,651,703 | $7.65M | 12.56% |
| 2 | DANAHER CORP | — | 12,280 | $2.59M | 4.24% |
| 3 | UCB SA | — | 8,299 | $2.47M | 4.06% |
| 4 | BOSTON SCIENTIFIC CORP | — | 32,000 | $2.46M | 4.04% |
| 5 | ARGENX SE SPONSORED ADR | — | 3,053 | $2.34M | 3.84% |
| 6 | COGENT BIOSCIENCES INC | — | 60,000 | $2.33M | 3.83% |
| 7 | ALNYLAM PHARMACEUTICALS INC | — | 6,060 | $2.02M | 3.31% |
| 8 | INTUITIVE SURGICAL INC | — | 3,800 | $1.91M | 3.14% |
| 9 | VEEVA SYSTEMS-A | — | 10,000 | $1.82M | 2.99% |
| 10 | INSULET CORP | — | 6,372 | $1.57M | 2.58% |
| 11 | MODERNA INC | — | 29,259 | $1.57M | 2.57% |
| 12 | WAYSTAR HOLDING CORP | — | 60,000 | $1.54M | 2.53% |
| 13 | EDWARDS LIFESCIENCES CORP | — | 17,421 | $1.51M | 2.47% |
| 14 | LIFESTANCE HEALTH GROUP INC | — | 206,792 | $1.50M | 2.46% |
| 15 | VAXCYTE INC | — | 22,513 | $1.39M | 2.28% |
| 16 | INSMED INC | — | 8,000 | $1.19M | 1.96% |
| 17 | Sartorius Stedim Biotech S.A. | DIM | 5,513 | $1.19M | 1.96% |
| 18 | STRYKER CORP | — | 2,925 | $1.13M | 1.86% |
| 19 | LILLY ELI and CO | — | 1,030 | $1.08M | 1.78% |
| 20 | PRIVIA HEALTH GROUP INC | — | 45,000 | $1.07M | 1.75% |
| 21 | THERMO FISHER SCIENTIFIC INC | — | 2,036 | $1.06M | 1.74% |
| 22 | LEGEND BIOTECH CORP SPON ADR | — | 55,400 | $1.05M | 1.73% |
| 23 | 10X GENOMICS INC | — | 45,000 | $1.04M | 1.70% |
| 24 | PENUMBRA INC | — | 3,000 | $1.03M | 1.70% |
| 25 | KYMERA THERAPEUTICS INC | — | 10,000 | $913.50K | 1.50% |
| 26 | STOKE THERAPEUTICS INC | — | 25,079 | $913.13K | 1.50% |
| 27 | Ascendis Pharma A/S | — | 3,865 | $902.48K | 1.48% |
| 28 | UNITEDHEALTH GRP | — | 2,973 | $871.89K | 1.43% |
| 29 | NATERA INC | — | 4,179 | $869.40K | 1.43% |
| 30 | LONZA GROUP -REG | — | 1,242 | $866.18K | 1.42% |
| 31 | CYTOKINETICS INC | — | 13,223 | $822.74K | 1.35% |
| 32 | CARIS LIFE SCIENCES INC | — | 40,000 | $805.60K | 1.32% |
| 33 | CRINETICS PHARMACEUTICALS INC | — | 19,000 | $780.90K | 1.28% |
| 34 | DEXCOM INC | — | 10,449 | $767.27K | 1.26% |
| 35 | DISC MEDICINE INC | — | 11,078 | $738.02K | 1.21% |
| 36 | VERACYTE INC | — | 20,000 | $731.80K | 1.20% |
| 37 | RESMED INC | — | 2,800 | $717.53K | 1.18% |
| 38 | XENON PHARMACEUTICALS INC | — | 15,658 | $676.90K | 1.11% |
| 39 | CENTESSA PHARMACEUTICALS LTD ADR | — | 22,800 | $612.41K | 1.00% |
| 40 | NUVALENT INC-A | — | 6,000 | $611.70K | 1.00% |
| 41 | CYTOMX THERAPEUTICS INC | — | 112,069 | $601.81K | 0.99% |
| 42 | ALIGNMENT HEALTHCARE INC | — | 30,094 | $578.41K | 0.95% |
| 43 | ALIGN TECHNOLOGY INC | — | 2,979 | $566.31K | 0.93% |
| 44 | GUARDANT HEALTH INC | — | 6,000 | $563.40K | 0.92% |
| 45 | WAVE LIFE SCIENCES LTD | — | 40,000 | $557.20K | 0.91% |
| 46 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | 12,000 | $533.88K | 0.88% |
| 47 | ROIVANT SCIENCES LTD | — | 18,000 | $520.92K | 0.85% |
| 48 | REPLIGEN CORP | — | 3,970 | $511.06K | 0.84% |
| 49 | ENLIVEN THERAPEUTICS INC | — | 17,123 | $508.38K | 0.83% |
| 50 | BIO-TECHNE CORP | — | 8,359 | $493.18K | 0.81% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.